Cargando…

New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy

For decades, intensive chemotherapy (IC) has been considered the best therapeutic option for treating acute myeloid leukemia (AML), with no curative option available for patients who are not eligible for IC or who have had failed IC. Over the last few years, several new drugs have enriched the thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreozzi, Fabio, Massaro, Fulvio, Wittnebel, Sebastian, Spilleboudt, Chloé, Lewalle, Philippe, Salaroli, Adriano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999556/ https://www.ncbi.nlm.nih.gov/pubmed/35409248 http://dx.doi.org/10.3390/ijms23073887

Ejemplares similares

SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
por: Alexandra, Van Uytvanck, et al.
Publicado: (2021)

Systematic review of dasatinib in chronic myeloid leukemia
por: Breccia, Massimo, et al.
Publicado: (2013)

SURPRISING ERYTHROCYTOSIS RESOLUTION AFTER MYOMECTOMY: MYOMATOUS ERYTHROCYTOSIS SYNDROME
por: Couillandre, Pauline, et al.
Publicado: (2023)

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease
por: Spilleboudt, Chloé, et al.
Publicado: (2021)

Supportive Care in Older Lymphoma Patients to Reduce Toxicity and Preserve Quality of Life
por: Massaro, Fulvio, et al.
Publicado: (2023)

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
por: Mannino, Gaia Chiara, et al.
Publicado: (2019)

Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs
por: Moussa Agha, Douâa, et al.
Publicado: (2020)

Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction
por: Moussa Agha, Douâa, et al.
Publicado: (2020)

Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinib
por: Breccia, Massimo, et al.
Publicado: (2017)

Low Incidence Rate of Opportunistic and Viral Infections During Imatinib Treatment in Chronic Myeloid Leukemia Patients in Early and Late Chronic Phase.
por: Breccia, Massimo, et al.
Publicado: (2011)

Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways
por: Otmani, Khalid, et al.
Publicado: (2023)

Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia
por: Högstrand, Kari, et al.
Publicado: (2012)

Analysis of rare driving events in pediatric acute myeloid leukemia
por: Noort, Sanne, et al.
Publicado: (2022)

Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
por: Nuno, Kevin A., et al.
Publicado: (2023)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

The Patient Perspective on Living with Acute Myeloid Leukemia
por: Tomaszewski, Erin L., et al.
Publicado: (2016)

Current perspectives for the treatment of chronic myeloid leukemia
por: ALADAĞ, Elifcan, et al.
Publicado: (2019)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013)

PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
por: Smith, Amanda M., et al.
Publicado: (2019)

A somatic mutation in moesin drives progression into acute myeloid leukemia
por: Yuan, Ouyang, et al.
Publicado: (2022)

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
por: Wang, Feng, et al.
Publicado: (2021)

Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018)

Bosutinib in chronic myeloid leukemia: patient selection and perspectives
por: Isfort, Susanne, et al.
Publicado: (2018)

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
por: Russo, Domenico, et al.
Publicado: (2020)

IL-17A and IL-2-Expanded Regulatory T Cells Cooperate to Inhibit Th1-Mediated Rejection of MHC II Disparate Skin Grafts
por: Vokaer, Benoît, et al.
Publicado: (2013)

Tailoring Immune Responses toward Autoimmunity: Transcriptional Regulators That Drive the Creation and Collusion of Autoreactive Lymphocytes
por: Good-Jacobson, Kim L., et al.
Publicado: (2018)

Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
por: Silla, Lucia Mariano da Rocha, et al.
Publicado: (2013)

Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
por: Smith, Amanda M., et al.
Publicado: (2020)

Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
por: Michelozzi, Ilaria M., et al.
Publicado: (2021)

Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia
por: Galán-Díez, Marta, et al.
Publicado: (2022)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Barakos, Georgios Petros, et al.
Publicado: (2022)

A tubulin binding molecule drives differentiation of acute myeloid leukemia cells
por: Jackson, Thomas R., et al.
Publicado: (2022)

A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia
por: Zhou, Fengbiao, et al.
Publicado: (2023)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia
por: Weeda, Vera, et al.
Publicado: (2022)

Recent advances in the path toward the cure for chronic myeloid leukemia
por: Kim, Dong-Wook
Publicado: (2011)

Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
por: Rabian, Florence, et al.
Publicado: (2019)

Advances in treating acute myeloid leukemia
por: Showel, Margaret M., et al.
Publicado: (2014)

Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment
por: Reed, Daniel R, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5pstvug903k4hj0ikamcrhjbuv